Assessment of Individual Cardiovascular Risk Among Population in Public Pharmacies Using the Heart-Score Questionnaire

1. Mirzaei M, Truswell AS, Taylor R, Leeder SR. Coronary heart disease epidemics: not all the same. Heart 2009;95:740–746.10.1136/hrt.2008.154856Search in Google Scholar

2. WHO. MONICA monograph and multimedia sourcebook. World s largest study of heart disease, stroke, risk factors and population trends 1979-2002. Tunstall-Pedoe H. ed, 2003.Search in Google Scholar

3. Nacionalni vodič za lekare u primarnoj zdravstvenoj zaštiti, Prevencija kardiovaskularnih bolesti, Republička stručna komisija za izradu i implementaciju vodiča u klinikoj praksi, Ministarstvo zdravlja Republike Srbije 2004.Search in Google Scholar

4. National Institute for Health and Clinical Excellence. Prevention of Cardiovascular Disease: Costing Report. 2010. Nice Public Health Guidance 25.Search in Google Scholar

5. Clark AM, Hartling L, Vandermeer B, McAlister FA. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med 2005;143:659–672.10.7326/0003-4819-143-9-200511010-00010Search in Google Scholar

6. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ 1994;309: 901–911.10.1136/bmj.309.6959.901Search in Google Scholar

7. Huisman M, Kunst AE, Mackenbach JP. Inequalities in the prevalence of smoking in the European Union: comparing education and income. Prev Med 2005;40: 756–764. 22. Edwards R. The problem of tobacco smoking. BMJ 2004;328:217–219. 215.10.1016/j.ypmed.2004.09.022Search in Google Scholar

8. Prescott E, Hippe M, Schnohr P, Hein HO, Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 1998; 316:1043–1047.10.1136/bmj.316.7137.1043Search in Google Scholar

9. World Health Organization. Global Health Observatory Data Repository.Search in Google Scholar

10. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid- artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.N Engl J Med1999;340:14–22.10.1056/NEJM199901073400103Search in Google Scholar

11. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987 – 1993. Am J Epidemiol1997;146:483–494.10.1093/oxfordjournals.aje.a009302Search in Google Scholar

12. US Department of Health and Human Services.2008 Physical Activity Guidelines for Americans. 2008Search in Google Scholar

13. Williams PT. Physical fitness and activity as separate heart disease risk factors: a meta- analysis.Med Sci Sports Exerc2001;33:754–761.10.1097/00005768-200105000-00012Search in Google Scholar

14. American College of Sports Medicine.ACSM’s Guidelines for Exercise Testing and Prescription. 8th ed. Baltimore, MD: Lippincott, Williams and Wilkins; 2009.Search in Google Scholar

15. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. World Health Organization Technical Report Series, Report No. 894. 1998.Search in Google Scholar

16. Fry J, Finley W. The prevalence and costs of obesity in the EU.Proc Nutr Soc 2005;64:359–362.10.1079/PNS2005443Search in Google Scholar

17. Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, Mookadam F, Lopez-Jimenez F. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006;368:666–678.10.1016/S0140-6736(06)69251-9Search in Google Scholar

18. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi- Sunyer FX, Eckel RH. Obesity, cardiovascular disease: pathophysiology, evaluation, effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006;113:898–918.10.1161/CIRCULATIONAHA.106.171016Search in Google Scholar

19. Freiberg MS, Pencina MJ, D’Agostino RB, Lanier K, Wilson PW, Vasan RS. BMI vs. waist circumference for identifying vascular risk. Obesity (Silver Spring) 2008;16: 463–469.10.1038/oby.2007.75Search in Google Scholar

20. Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008;359:2105–2120.10.1056/NEJMoa0801891Search in Google Scholar

21. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903–1913.10.1016/S0140-6736(02)11911-8Search in Google Scholar

22. Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, Kannel WB, Levy D. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 2001;103:1245–1249.10.1161/01.CIR.103.9.1245Search in Google Scholar

23. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.J Hypertens 2009;27:2121–2158.10.1097/HJH.0b013e328333146d19838131Search in Google Scholar

24. O’Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003;21: 821–848.10.1097/00004872-200305000-0000112714851Search in Google Scholar

25. Verberk W, Kroon AA, de Leeuw PW. Masked hypertension and white-coat hypertension prognosis. J Am Coll Cardiol 2006;47:2127; author reply 2127–2128.10.1016/j.jacc.2006.02.03616697339Search in Google Scholar

26. Ministarstvo zdravlja Srbije. Istraživanje zdravlja stanovnika republike Srbije. 2013.IzveštajSearch in Google Scholar

27. Cooney MT, Dudina A, De Bacquer D, Fitzgerald A, Conroy R, Sans S, Menotti A, De Backer G, Jousilahti P, Keil U, Thomsen T, Whincup P, Graham I. How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators. Eur J Cardiovasc Prev Rehabil 2009;16:304–314.10.1097/HJR.0b013e328321314019609139Search in Google Scholar

28. Cooney MT, Dudina A, De Bacquer D, Wilhelmsen L, Sans S, Menotti A, De Backer G, Jousilahti P, Keil U, Thomsen T, Whincup P, Graham IM. HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk. Atherosclerosis 2009;206:611–616.10.1016/j.atherosclerosis.2009.02.04119375079Search in Google Scholar

29. https://www.heartscore.org last visit 27/07/2020.Search in Google Scholar

30. UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854–865.10.1016/S0140-6736(98)07037-8Search in Google Scholar

31. Albus C, Jordan J, Herrmann-Lingen C. Screening for psychosocial risk factors in patients with coronary heart disease—recommendations for clinical practice. Eur J Cardiovasc Prev Rehabil2004;11:75–79.10.1097/01.hjr.0000116823.84388.6cSearch in Google Scholar

32. Rozanski A, Blumenthal JA, Davidson KW, Saab PG, Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol 2005;45: 637–651.10.1016/j.jacc.2004.12.005Search in Google Scholar

33. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.Lancet2009; 373:929–940.10.1016/S0140-6736(09)60330-5Search in Google Scholar

34. Rayner M, Allender S, Scarborough P. Cardiovascular disease in Europe.Eur J Cardiovasc Prev Rehabil2009; 16Suppl 2:S43 –S4710.1097/01.hjr.0000359235.59808.baSearch in Google Scholar

35. Cuende JI, Cuende N, Calaveras-Lagartos J. How to calculate vascular age with the SCORE project scales: a new method of cardiovascular risk evaluation. Eur Heart J 2010;31:2351–2358.10.1093/eurheartj/ehq205Search in Google Scholar

36. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall- Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987–1003.10.1016/S0195-668X(03)00114-3Search in Google Scholar

37. Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr 2010;92:1189–1196.10.3945/ajcn.2010.29673Search in Google Scholar

38. Conroy R.M., Pyörälä K., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. European Heart Journal 2003;24:987-1003.10.1016/S0195-668X(03)00114-3Search in Google Scholar

39. Lakic D, Tasic Lj, Kos M. Economic burden of cardiovascular disease in Serbia. Vojnosanit Pregled 2014; 71(2): 137-147.10.2298/VSP1402137L24665570Search in Google Scholar